₹982.90
₹-3.70 (-0.38%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹9,095 Cr
P/E
14.34
ROE
17.90%
ROCE
17.30%
About Strides Pharma Science Ltd
Strides Pharma Science into the development and manufacture of pharmaceutical products.
Founded
1990
CEO
Arun Kumar
Employees
5,394
HQ
Bangalore, India
About Strides Pharma Science Ltd
Strides Pharma Science into the development and manufacture of pharmaceutical products.
Founded:1990
CEO:Arun Kumar
Employees:5,394
HQ:Bangalore, India
Finished Products
1Sale of Products
₹5,577.27Cr2Other Operating Income
₹93.55Cr3Export incentives
₹55.84Cr4Saleof Intellectual Prop.Right
₹55.82Cr5Sale of Services
₹26.53Cr6Support Service Income
₹25.12Cr7Development Income
₹14.69Cr1–7 of 9
Raw Materials
1Raw Materials consumed
₹3,056.16Cr2Others-Purchases
₹91.86Cr3Finished Goods Purchased
₹51.83CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,231
52W Low
₹769
Volume97.63K
Avg VolumeN/A
Beta0.64
Dividend Yield0.51%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
14.34x
Valuation
P/B Ratio
2.93x
Valuation
EPS
₹68.83
Valuation
Dividend Yield
0.51%
Valuation
ROE
17.90%
Profitability
ROCE
17.30%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical business
+9.8%100.0%
₹4,051.12 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.4%
International
99.6%
North America53.8%
Europe22.2%
Africa11.9%
Australia11.0%
Others0.4%
India0.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
P
Pharmagel s r 1
Italy
0.00% stakeA
Arcolab S A
Switzerland
0.00% stakeM
M/s Kathabar Systems
Holland
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.57x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.